Table 3 Advanced gastric cancers with gene amplification

From: Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization

Case No.

Histological classification

Anatomic stage /prognostic groups

Neoajduvant therapy

FISH findings of amplified genes

    

ERBB2

TOP2A

FGFR2

MET

EGFR

MYC

MDM2

CCND1

FGF10

1

Tub

IV

 

HSR (>70)

        

2

Tub

IV

DCS

HSR (>70)

HSR (>70)

       

3

Por

IV

DCS/Herceptin

DM (>70)

        

4

Tub

IV

 

Low amp (30–70)

     

HSR (30–70)

  

5

Tub

IV

 

HSR (>70)

    

Low amp (>70)

   

6

Tub

IV

DCS

HSR (>70)

Low amp (>70)

       

7

Tub

IIIC

DCS

HSR (30–70)

 

DM (30–70)

      

8

Tub

IIIB

DCS

DM (>70)

DM (30–70)

       

9

Tub

IIIB

S-1

Co-amp HSR (>70)

co-amp HSR (>70)

   

High poly (>70)

  

Low amp (>70)

10

Tub

IIIA

 

Low amp (>70)

Low amp (>70)

       

11

Tub

IIIA

 

HSR (>70)

HSR (>70)

       

12

Tub

IIA

 

Co-amp HSR (>70)

co-amp HSR (>70)

   

HSR (>70)

   

13

Tub

IIA

 

HSR (30-70)

        

14

Por

IV

   

DM (30-70)

      

15

Por

IV

   

High poly (30–70)

    

HSR (30–70)

 

16

Por

IIIB

DCS

  

DM (30–70)

      

17

Por

IIIA

   

DM (<30)

   

DM (<30)

  

18

Por

IIA

   

HSR (>70)

      

19

Tub

IIA

   

DM (30-70)

      

20

Por

IV

DCS

   

Low amp (>70)

     

21

Tub

IV

DCS

   

DM (30–70)

     

22

Por

IV

DCS

   

HSR (30–70)

     

23

Muc

IIIA

    

HSR (30–70)

     

24

Tub

IIIA

     

DM (>70)

  

HSR (>70)

 

25

Por

IV

DCS

     

HSR (>70)

   

26

Por

IV

      

DM>>HSR (30–70)

  

HSR (>70)

27

Por

IIIB

S-1/DOC

     

DM (30–70)

   

28

Pap

IIB

      

HSR (30–70)

   

29

Por

IIIA

DCS

       

Low amp> DM (>70)

 

30

Tub

IV

       

Low amp (>70)

  

31

Por

IIA

DCS

      

DM (30–70)

  

32

Mixed

IIIA

DCS

        

Low amp (>70)

Numbers of cases with gene amplification

   

13

7

7

4

1

7

4

3

2

Fraction (%) of cases with gene amplification

   

14

8

8

4

1

8

4

3

3

  1. Abbreviations: Co-amp HSR, co-amplification of a gene and the centromeric lesion in HSR; DCS, combination chemotherapy with docetaxcel cisplatin, and S-1; DM, double minute chromosome type amplification; DOC, docetaxcel; high poly, high polysomy; HSR, homogeneously staining region type amplification; low amp, low amplification.; mixed, mixed carcinoma; muc, mucinous carcinoma; pap, papillary adenocarcinoma; Por, poorly cohesive adenocarcinoma; Tub, tubular adenocarcinoma.
  2. Numbers in parentheses indicate % of the amplified cells in each case.